The effect of Cilostazol on the mean time of arteriovenous fistula maturation and its comparison to control group in patients with chronic renal failure referring to Emam Reza hospital of Mashhad University of Medical Sciences.

The effect of Cilostazol on the mean time of arteriovenous fistula maturation and its comparison to control group in patients with chronic renal failure referring to Emam Reza hospital of Mashhad University of Medical Sciences

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20171023036953N1

Enrollment

Registered

2017-12-18

Start date

2016-08-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

renal failure. Chronic kidney disease, stage 5

Interventions

Cilostazol was prescribed from the day of surgery at a dose of 50mg / day for two weeks, then continued 100mg / day for ten weeks or until fistula maturation..

Prevention

Cilostazol was prescribed from the day of surgery at a dose of 50mg / day for two weeks, then continued 100mg / day for ten weeks or until fistula maturation.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria:

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Fistula maturation. Timepoint: 3 weeks. Method of measurement: doppler sonography.	—

Secondary

Measure	Time frame
Fistula flow rate -distance from skin_vein diameter. Timepoint: 3 weeks. Method of measurement: doppler sonography.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Ali Saberi

ALAVI HOSPITAL

alisaberi.md@gmail.com+98 51 3851 3258

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026